Ubisoft, a titan in the gaming industry, is cautiously reviving hopes for the iconic Splinter Cell series after four years of silence. This article explores the challenges faced by developers, the ...

Read here for insights on Lineage’s cell therapy pipeline, key partnerships, and 2026 catalysts. Learn why now may be the ...

Genomics, Inc. (NASDAQ:TXG) is one of the best digital health stocks to buy now. On October 29, 2025, 10x Genomics announced ...

Using sophisticated RNA sequencing technology, biomedical researchers can measure the activity of our genes across millions ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a definitive agreement to fully ...

In a groundbreaking application of graphene technology, the first graphene-based solar cells have been successfully utilized ...

Sometimes big breakthroughs in science come from very small changes, curiosity, and more than a little luck. A new study from ...

Stem cells possess the unique abilities of self-renewal and differentiation into various cell types, making them highly ...

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

In a town on the shores of Lake Geneva sit clumps of living human brain cells for hire. These blobs, about the size of a ...